Increased superoxide dismutase and Down’s syndrome
- 30 June 2001
- journal article
- Published by Elsevier in Medical Hypotheses
- Vol. 56 (6), 617-619
- https://doi.org/10.1054/mehy.2001.1327
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Antioxidants and dementiaThe Lancet, 1997
- Overexpression of copper-zinc superoxide dismutase in trisomy 21Cellular and Molecular Life Sciences, 1996
- Impaired copper binding by the H46R mutant of human Cu,Zn superoxide dismutase, involved in amyotrophic lateral sclerosisFEBS Letters, 1994
- A New Variant Cu/Zn Superoxide Dismutase (Val7→Glu) Deduced from Lymphocyte mRNA Sequences from Japanese Patients with Familial Amyotrophic Lateral SclerosisBiochemical and Biophysical Research Communications, 1994
- Identification of two novel mutations and a new polymorphism in the gene for Cu/Zn superoxide dismutase in patients with amyotrophic lateral sclerosisHuman Molecular Genetics, 1994
- Transgenic mice with expression of elevated levels of copper-zinc superoxide dismutase in the lungs are resistant to pulmonary oxygen toxicity.Journal of Clinical Investigation, 1991
- Oxidative stress in trisomy 21: A possible role in cataractogenesisOphthalmic Paediatrics and Genetics, 1989
- Down's syndrome: Abnormal neuromuscular junction in tongue of transgenic mice with elevated levels of human Cu/Zn-superoxide dismutaseCell, 1988
- Regular trisomy 21 not accompanied by increased copper‐zinc superoxide dismutase (SOD1) activityClinical Genetics, 1988
- Superoxide dismutase inhibits the superoxide‐driven Fenton reaction at two different levelsFEBS Letters, 1985